186 related articles for article (PubMed ID: 31561444)
1. BET Proteins Are Required for Transcriptional Activation of the Senescent Islet Cell Secretome in Type 1 Diabetes.
Thompson PJ; Shah A; Apostolopolou H; Bhushan A
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561444
[TBL] [Abstract][Full Text] [Related]
2. DNA damage to β cells in culture recapitulates features of senescent β cells that accumulate in type 1 diabetes.
Brawerman G; Pipella J; Thompson PJ
Mol Metab; 2022 Aug; 62():101524. PubMed ID: 35660116
[TBL] [Abstract][Full Text] [Related]
3. Exploring Transcriptional Regulation of Beta Cell SASP by Brd4-Associated Proteins and Cell Cycle Control Protein p21.
Manji J; Pipella J; Brawerman G; Thompson PJ
Epigenomes; 2024 Mar; 8(1):. PubMed ID: 38534794
[TBL] [Abstract][Full Text] [Related]
4. Alpha cell dysfunction in type 1 diabetes is independent of a senescence program.
Brawerman G; Ntranos V; Thompson PJ
Front Endocrinol (Lausanne); 2022; 13():932516. PubMed ID: 36277717
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
[TBL] [Abstract][Full Text] [Related]
6.
Nord JA; Wynia-Smith SL; Gehant AL; Jones Lipinski RA; Naatz A; Rioja I; Prinjha RK; Corbett JA; Smith BC
Front Endocrinol (Lausanne); 2022; 13():923925. PubMed ID: 36176467
[TBL] [Abstract][Full Text] [Related]
7. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes.
Thompson PJ; Shah A; Ntranos V; Van Gool F; Atkinson M; Bhushan A
Cell Metab; 2019 May; 29(5):1045-1060.e10. PubMed ID: 30799288
[TBL] [Abstract][Full Text] [Related]
8. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Redd S; Ginn S; Ross JM
Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
[TBL] [Abstract][Full Text] [Related]
9. Unique Human and Mouse β-Cell Senescence-Associated Secretory Phenotype (SASP) Reveal Conserved Signaling Pathways and Heterogeneous Factors.
Midha A; Pan H; Abarca C; Andle J; Carapeto P; Bonner-Weir S; Aguayo-Mazzucato C
Diabetes; 2021 May; 70(5):1098-1116. PubMed ID: 33674410
[TBL] [Abstract][Full Text] [Related]
10. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.
Moore DJ; Zienkiewicz J; Kendall PL; Liu D; Liu X; Veach RA; Collins RD; Hawiger J
PLoS One; 2010 Oct; 5(10):e13235. PubMed ID: 20949090
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
[TBL] [Abstract][Full Text] [Related]
12. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
13. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
[TBL] [Abstract][Full Text] [Related]
14. Exocytosis Protein DOC2B as a Biomarker of Type 1 Diabetes.
Aslamy A; Oh E; Ahn M; Moin ASM; Chang M; Duncan M; Hacker-Stratton J; El-Shahawy M; Kandeel F; DiMeglio LA; Thurmond DC
J Clin Endocrinol Metab; 2018 May; 103(5):1966-1976. PubMed ID: 29506054
[TBL] [Abstract][Full Text] [Related]
15. Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development.
Green-Mitchell SM; Tersey SA; Cole BK; Ma K; Kuhn NS; Cunningham TD; Maybee NA; Chakrabarti SK; McDuffie M; Taylor-Fishwick DA; Mirmira RG; Nadler JL; Morris MA
PLoS One; 2013; 8(2):e56763. PubMed ID: 23437231
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice.
Kornete M; Beauchemin H; Polychronakos C; Piccirillo CA
Autoimmunity; 2013 Jun; 46(4):259-68. PubMed ID: 23256897
[TBL] [Abstract][Full Text] [Related]
18. Abnormal islet sphingolipid metabolism in type 1 diabetes.
Holm LJ; Krogvold L; Hasselby JP; Kaur S; Claessens LA; Russell MA; Mathews CE; Hanssen KF; Morgan NG; Koeleman BPC; Roep BO; Gerling IC; Pociot F; Dahl-Jørgensen K; Buschard K
Diabetologia; 2018 Jul; 61(7):1650-1661. PubMed ID: 29671030
[TBL] [Abstract][Full Text] [Related]
19. BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance.
Tasdemir N; Banito A; Roe JS; Alonso-Curbelo D; Camiolo M; Tschaharganeh DF; Huang CH; Aksoy O; Bolden JE; Chen CC; Fennell M; Thapar V; Chicas A; Vakoc CR; Lowe SW
Cancer Discov; 2016 Jun; 6(6):612-29. PubMed ID: 27099234
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of physical exercise for β-cell maintenance in a type 1 diabetes mellitus animal model.
Villaça CBP; de Paula CC; de Oliveira CC; Vilas-Boas EA; Dos Santos-Silva JC; de Oliveira SF; Abdulkader F; Ferreira SM; Ortis F
Exp Physiol; 2021 Jul; 106(7):1482-1497. PubMed ID: 33913203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
